LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Details
- Status
- Prescription
- First Approved
- 1972-02-23
- Routes
- INJECTION, IONTOPHORESIS, TOPICAL
- Dosage Forms
- INJECTABLE, SOLUTION
Companies
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Approval History
What LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Treats
8 FDA approvalsOriginally approved for its first indication in 1972 . Covers 8 distinct patient populations.
- Other (8)
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE FDA Label Details
ProIndications & Usage
FDA Label (PDF)Lidocaine Hydrochloride and Epinephrine Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.